Cell Signaling Technology

TUT4 (E9D9T) Rabbit Monoclonal Antibody

#15627 · $161,351

69
Citing papers
4.2k
Combined citations
Supplier page Find this product

Research areas

Genetics and Neurodevelopmental Disorders21Neuroscience and Neuropharmacology Research12Ubiquitin and proteasome pathways10PI3K/AKT/mTOR signaling in cancer9Autism Spectrum Disorder Research5MicroRNA in disease regulation4Mitochondrial Function and Pathology4Ion channel regulation and function3

Papers citing this product

1
Mutations causing syndromic autism define an axis of synaptic pathophysiology
Nature·2011·598 cit.·DOI
2
Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway
PLoS ONE·2009·395 cit.·DOI
3
Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome
Journal of Neuroscience·2010·384 cit.·DOI
4
Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death
Cell Death and Disease·2016·235 cit.·DOI
5
Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells
International Journal of Oncology·2012·221 cit.·DOI
6
Regulation of mTOR Complex 1 (mTORC1) by Raptor Ser863 and Multisite Phosphorylation
Journal of Biological Chemistry·2009·193 cit.·DOI
7
Anticancer Effects of Resveratrol-Loaded Solid Lipid Nanoparticles on Human Breast Cancer Cells
Molecules·2017·129 cit.·DOI
8
YAP regulates PD-L1 expression in human NSCLC cells
Oncotarget·2017·128 cit.·DOI
9
Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity Is Associated with Phosphorylation of Raptor by mTOR
Journal of Biological Chemistry·2009·117 cit.·DOI
10
Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo
Journal of Neuroscience·2016·108 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.